(-)-cotinine multiple interactions ISO RGD:1344668 6480464 NAT1 gene polymorphism affects the reaction [Tobacco Smoke Pollution results in increased abundance of Cotinine] CTD PMID:25156213 (-)-cotinine affects abundance ISO RGD:1344668 6480464 NAT1 gene polymorphism affects the abundance of Cotinine CTD PMID:25156213 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1344668 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NAT1 mRNA CTD PMID:22079256 1,4-dithiothreitol increases activity ISO RGD:1344668 6480464 Dithiothreitol results in increased activity of NAT1 protein CTD PMID:22835378 1,4-dithiothreitol multiple interactions ISO RGD:1344668 6480464 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of NAT1 protein] CTD PMID:22835378 1,4-phenylenediamine increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of 4-phenylenediamine CTD PMID:15350687 1,4-phenylenediamine multiple interactions ISO RGD:1344668 6480464 4-phenylenediamine results in decreased activity of and results in decreased expression of NAT1 protein CTD PMID:20406859 17beta-estradiol multiple interactions ISO RGD:1344668 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NAT1 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NAT1 mRNA CTD PMID:19619570 , PMID:20660070 17beta-estradiol increases expression ISO RGD:1344668 6480464 Estradiol results in increased expression of NAT1 mRNA CTD PMID:19619570 17beta-estradiol decreases expression ISO RGD:1344668 6480464 Estradiol results in decreased expression of NAT1 mRNA CTD PMID:23019147 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1344668 6480464 Dihydrotestosterone results in increased expression of NAT1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1344668 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344668 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NAT1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAT1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344668 6480464 Tetrachlorodibenzodioxin results in increased expression of NAT1 mRNA CTD PMID:19619570 , PMID:21632981 2,4-dinitrotoluene affects expression ISO RGD:70490 6480464 2, 4-dinitrotoluene affects the expression of NAT1 mRNA CTD PMID:21346803 2-acetamidofluorene increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of 2-Acetylaminofluorene CTD PMID:15450435 2-naphthylamine increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of 2-Naphthylamine CTD PMID:15450435 3,3'-Dimethylbenzidine increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of 2-tolidine CTD PMID:15450435 3H-1,2-dithiole-3-thione decreases expression ISO RGD:70490 6480464 1, 2-dithiol-3-thione results in decreased expression of NAT1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases acetylation ISO RGD:70490 6480464 NAT1 protein results in increased acetylation of 4, 4'-diaminodiphenylmethane CTD PMID:16192314 4-aminobenzoic acid multiple interactions ISO RGD:1344668 6480464 Dehydroepiandrosterone Sulfate inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid] more ... CTD PMID:11470991 4-aminobenzoic acid increases metabolic processing ISO RGD:1344668 6480464 NAT1 protein results in increased metabolism of 4-Aminobenzoic Acid CTD PMID:30358977 4-aminobenzoic acid affects acetylation ISO RGD:1344668 6480464 NAT1 protein affects the acetylation of 4-Aminobenzoic Acid CTD PMID:29043425 4-aminobenzoic acid increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid CTD PMID:11470991 more ... 4-aminosalicylic acid increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of Aminosalicylic Acid CTD PMID:15627487 , PMID:16003948 4-chloroaniline increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of 4-chloroaniline CTD PMID:15627487 acetyl-CoA multiple interactions ISO RGD:1344668 6480464 [NQO1 protein co-treated with NADP co-treated with Acetyl Coenzyme A co-treated with NAT1 protein] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone more ... CTD PMID:20545351 , PMID:22835378 acetyl-CoA affects binding ISO RGD:1344668 6480464 Acetyl Coenzyme A binds to NAT1 protein CTD PMID:22835378 acetylsalicylic acid decreases activity ISO RGD:70490 6480464 Aspirin results in decreased activity of NAT1 protein CTD PMID:15796213 acrolein multiple interactions ISO RGD:1344668 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NAT1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NAT1 mRNA CTD PMID:32699268 aflatoxin B1 multiple interactions ISO RGD:1344668 6480464 [CYP3A7 co-treated with NAT1] results in increased susceptibility to Aflatoxin B1 CTD PMID:7625840 aflatoxin B1 increases expression ISO RGD:1344668 6480464 Aflatoxin B1 results in increased expression of NAT1 mRNA CTD PMID:31542801 aflatoxin B1 decreases methylation ISO RGD:1344668 6480464 Aflatoxin B1 results in decreased methylation of NAT1 gene CTD PMID:27153756 Aloe emodin multiple interactions ISO RGD:1344668 6480464 aloe emodin results in decreased expression of and results in decreased activity of NAT1 protein CTD PMID:16314733 Aloe emodin decreases expression ISO RGD:1344668 6480464 aloe emodin results in decreased expression of NAT1 mRNA CTD PMID:16314733 alpha-pinene multiple interactions ISO RGD:1344668 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NAT1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NAT1 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:70490 6480464 Ammonium Chloride affects the expression of NAT1 mRNA CTD PMID:16483693 anilines increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of Aniline Compounds analog CTD PMID:15627487 antirheumatic drug decreases expression ISO RGD:1344668 6480464 Antirheumatic Agents results in decreased expression of NAT1 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:1344668 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of NAT1 mRNA CTD PMID:17851650 baicalein decreases expression ISO RGD:1344668 6480464 baicalein results in decreased expression of NAT1 mRNA, baicalein results in decreased expression of NAT1 protein CTD PMID:15796204 benzidine increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of benzidine CTD PMID:15450435 benzo[a]pyrene affects response to substance ISO RGD:1344668 6480464 NAT1 protein affects the susceptibility to Benzoapyrene CTD PMID:18499698 benzo[a]pyrene affects methylation ISO RGD:1344668 6480464 Benzoapyrene affects the methylation of NAT1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1344668 6480464 Benzoapyrene results in increased expression of NAT1 mRNA CTD PMID:31542801 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1344668 6480464 7 more ... CTD PMID:19150397 bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of NAT1 mRNA CTD PMID:26071804 biphenyl-4-amine increases metabolic processing EXP 6480464 NAT1 protein results in increased metabolism of 4-biphenylamine CTD PMID:16815960 biphenyl-4-amine multiple interactions ISO RGD:1344668 6480464 [NAT1 polymorphism results in increased susceptibility to 4-biphenylamine] which results in increased mutagenesis of HPRT1 gene CTD PMID:22114069 biphenyl-4-amine increases response to substance ISO RGD:1344668 6480464 NAT1 polymorphism results in increased susceptibility to 4-biphenylamine, NAT1 protein polymorphism results in increased susceptibility to 4-biphenylamine CTD PMID:22010219 , PMID:22114069 biphenyl-4-amine affects response to substance ISO RGD:1344668 6480464 NAT1 mRNA alternative form affects the susceptibility to 4-biphenylamine CTD PMID:21837760 biphenyl-4-amine increases acetylation ISO RGD:1344668 6480464 NAT1 protein polymorphism results in increased acetylation of 4-biphenylamine, NAT1 protein results in increased acetylation of 4-biphenylamine CTD PMID:12088197 , PMID:22010219 biphenyl-4-amine increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of 4-biphenylamine CTD PMID:15450435 bisphenol A affects expression ISO RGD:70490 6480464 bisphenol A affects the expression of NAT1 mRNA CTD PMID:25181051 butyric acid increases expression ISO RGD:1344668 6480464 Butyric Acid results in increased expression of NAT1 mRNA CTD PMID:30439556 cadmium dichloride multiple interactions ISO RGD:1344668 6480464 Cadmium Chloride binds to and results in decreased activity of NAT1 protein CTD PMID:20810355 cadmium dichloride decreases methylation ISO RGD:70490 6480464 Cadmium Chloride results in decreased methylation of NAT1 promoter CTD PMID:22457795 calcitriol increases expression ISO RGD:1344668 6480464 Calcitriol results in increased expression of NAT1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1344668 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NAT1 mRNA CTD PMID:21592394 carbamazepine increases expression ISO RGD:1344668 6480464 Carbamazepine results in increased expression of NAT1 mRNA CTD PMID:17112801 carotenoid affects response to substance ISO RGD:1344668 6480464 NAT1 protein polymorphism affects the susceptibility to Carotenoids CTD PMID:15095308 clofibric acid affects expression ISO RGD:70490 6480464 Clofibric Acid affects the expression of NAT1 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:70490 6480464 cobaltous chloride results in decreased expression of NAT1 mRNA CTD PMID:24386269 CU-O LINKAGE increases expression ISO RGD:1344668 6480464 cupric oxide results in increased expression of NAT1 mRNA CTD PMID:32285662 cyanamide decreases activity ISO RGD:1344668 6480464 Cyanamide results in decreased activity of NAT1 protein CTD PMID:22835378 cyanamide multiple interactions ISO RGD:1344668 6480464 Acetyl Coenzyme A inhibits the reaction [Cyanamide results in decreased activity of NAT1 protein] CTD PMID:22835378 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of NAT1 mRNA CTD PMID:23830897 cyclosporin A decreases expression ISO RGD:1344668 6480464 Cyclosporine results in decreased expression of NAT1 mRNA CTD PMID:20106945 , PMID:23830897 cylindrospermopsin increases expression ISO RGD:1344668 6480464 cylindrospermopsin results in increased expression of NAT1 mRNA CTD PMID:23726867 dehydroepiandrosterone sulfate multiple interactions ISO RGD:1344668 6480464 Dehydroepiandrosterone Sulfate inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid], Dehydroepiandrosterone Sulfate promotes the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid] CTD PMID:11470991 dibutyl phthalate decreases expression ISO RGD:70490 6480464 Dibutyl Phthalate results in decreased expression of NAT1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1344668 6480464 dicrotophos results in decreased expression of NAT1 mRNA CTD PMID:28302478 dihydrofolic acid decreases activity ISO RGD:1344668 6480464 dihydrofolate results in decreased activity of NAT1 protein CTD PMID:16003948 diphenylmethane-4,4'-diisocyanate increases response to substance ISO RGD:1344668 6480464 NAT1 protein polymorphism results in increased susceptibility to 4, 4'-diphenylmethane diisocyanate CTD PMID:11927838 dorsomorphin multiple interactions ISO RGD:1344668 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 endosulfan decreases expression ISO RGD:70490 6480464 Endosulfan results in decreased expression of NAT1 mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO RGD:1344668 6480464 Ethyl Methanesulfonate results in increased expression of NAT1 mRNA CTD PMID:23649840 flavonoids decreases expression ISO RGD:70490 6480464 Flavonoids results in decreased expression of NAT1 mRNA CTD PMID:18035473 flutamide increases expression ISO RGD:70490 6480464 Flutamide results in increased expression of NAT1 mRNA CTD PMID:24793618 folic acid decreases activity ISO RGD:1344668 6480464 Folic Acid results in decreased activity of NAT1 protein, Folic Acid results in decreased activity of NAT1 protein modified form CTD PMID:16003948 folic acid increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of Folic Acid metabolite CTD PMID:15627487 formaldehyde increases expression ISO RGD:1344668 6480464 Formaldehyde results in increased expression of NAT1 mRNA CTD PMID:23649840 hexamethylene diisocyanate increases response to substance ISO RGD:1344668 6480464 NAT1 protein polymorphism results in increased susceptibility to 1, 6-hexamethylene diisocyanate CTD PMID:11927838 hydrogen peroxide decreases activity ISO RGD:1344668 6480464 Hydrogen Peroxide results in decreased activity of NAT1 protein CTD PMID:15644493 more ... hydrogen peroxide multiple interactions ISO RGD:1344668 6480464 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of NAT1 protein] CTD PMID:22835378 indometacin increases expression ISO RGD:70490 6480464 Indomethacin results in increased expression of NAT1 mRNA CTD PMID:16184411 L-1,4-dithiothreitol increases activity ISO RGD:1344668 6480464 Dithiothreitol results in increased activity of NAT1 protein CTD PMID:22835378 L-1,4-dithiothreitol multiple interactions ISO RGD:1344668 6480464 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of NAT1 protein] CTD PMID:22835378 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of NAT1 mRNA CTD PMID:22609695 linsidomine decreases activity ISO RGD:1344668 6480464 linsidomine results in decreased activity of NAT1 protein CTD PMID:14672957 mercury atom multiple interactions ISO RGD:1344668 6480464 Mercury binds to and results in decreased activity of NAT1 protein CTD PMID:20591428 mercury dibromide increases expression ISO RGD:1344668 6480464 mercuric bromide results in increased expression of NAT1 mRNA CTD PMID:26272509 mercury(0) multiple interactions ISO RGD:1344668 6480464 Mercury binds to and results in decreased activity of NAT1 protein CTD PMID:20591428 mesalamine increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of Mesalamine CTD PMID:15627487 methapyrilene decreases expression ISO RGD:70490 6480464 Methapyrilene results in decreased expression of NAT1 mRNA CTD PMID:30467583 methotrexate decreases activity ISO RGD:1344668 6480464 Methotrexate results in decreased activity of NAT1 protein, Methotrexate results in decreased activity of NAT1 protein modified form CTD PMID:16003948 methyl methanesulfonate increases expression ISO RGD:1344668 6480464 Methyl Methanesulfonate results in increased expression of NAT1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1344668 6480464 methylmercuric chloride results in decreased expression of NAT1 mRNA CTD PMID:23179753 , PMID:27188386 N-hydroxy-2-acetamidofluorene decreases activity ISO RGD:1344668 6480464 Hydroxyacetylaminofluorene results in decreased activity of NAT1 protein CTD PMID:19842618 N-hydroxy-4-acetylaminobiphenyl decreases activity ISO RGD:1344668 6480464 N-hydroxy-4-acetylaminobiphenyl results in decreased activity of NAT1 protein CTD PMID:15720122 N-hydroxy-PhIP multiple interactions ISO RGD:1344668 6480464 NAT1 protein affects the acetylation of and affects the activity of 2-hydroxyamino-1-methyl-6-phenylimidazo4, 5-bpyridine CTD PMID:11505221 N-hydroxy-PhIP increases metabolic processing ISO RGD:1344668 6480464 NAT1 protein results in increased metabolism of 2-hydroxyamino-1-methyl-6-phenylimidazo4, 5-bpyridine CTD PMID:29596660 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of NAT1 mRNA CTD PMID:24535843 N-nitrosodiethylamine decreases expression ISO RGD:1344668 6480464 Diethylnitrosamine results in decreased expression of NAT1 mRNA CTD PMID:21527772 NADP zwitterion multiple interactions ISO RGD:1344668 6480464 [NQO1 protein co-treated with NADP co-treated with Acetyl Coenzyme A co-treated with NAT1 protein] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone CTD PMID:20545351 NADP(+) multiple interactions ISO RGD:1344668 6480464 [NQO1 protein co-treated with NADP co-treated with Acetyl Coenzyme A co-treated with NAT1 protein] results in increased activity of and results in increased reduction of 3-nitrobenzanthrone CTD PMID:20545351 o-anisidine increases activity ISO RGD:1344668 6480464 NAT1 protein results in increased activity of 2-anisidine CTD PMID:15450435 ozone multiple interactions ISO RGD:1344668 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NAT1 mRNA more ... CTD PMID:32699268 p-anisidine increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of 4-anisidine CTD PMID:15627487 p-chloromercuribenzoic acid increases expression ISO RGD:1344668 6480464 p-Chloromercuribenzoic Acid results in increased expression of NAT1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1344668 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NAT1 mRNA CTD PMID:27188386 paclitaxel decreases activity ISO RGD:1344668 6480464 Paclitaxel results in decreased activity of NAT1 mRNA, Paclitaxel results in decreased activity of NAT1 protein CTD PMID:17564303 paclitaxel decreases expression ISO RGD:1344668 6480464 Paclitaxel results in decreased expression of NAT1 mRNA CTD PMID:15015580 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of NAT1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:70490 6480464 Acetaminophen results in increased expression of NAT1 protein CTD PMID:16538041 pentachlorophenol multiple interactions ISO RGD:1344668 6480464 Pentachlorophenol inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid] CTD PMID:11470991 pentachlorophenol decreases activity ISO RGD:1344668 6480464 Pentachlorophenol results in decreased activity of NAT1 protein CTD PMID:29596660 peroxynitrous acid decreases activity ISO RGD:1344668 6480464 Peroxynitrous Acid results in decreased activity of NAT1 protein CTD PMID:14672957 , PMID:15644493 phenylmercury acetate increases expression ISO RGD:1344668 6480464 Phenylmercuric Acetate results in increased expression of NAT1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344668 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NAT1 mRNA CTD PMID:27188386 PhIP affects response to substance ISO RGD:1344668 6480464 NAT1 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine CTD PMID:18499698 PhIP increases expression ISO RGD:1344668 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of NAT1 mRNA CTD PMID:31542801 potassium chromate decreases expression ISO RGD:1344668 6480464 potassium chromateVI results in decreased expression of NAT1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1344668 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NAT1 mRNA CTD PMID:22079256 procainamide increases acetylation ISO RGD:1344668 6480464 NAT1 protein results in increased acetylation of Procainamide CTD PMID:16003948 progesterone multiple interactions ISO RGD:1344668 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NAT1 mRNA CTD PMID:20660070 resveratrol increases expression ISO RGD:70490 6480464 resveratrol results in increased expression of NAT1 mRNA CTD PMID:19228061 SB 431542 multiple interactions ISO RGD:1344668 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1344668 6480464 sodium arsenite results in increased expression of NAT1 mRNA CTD PMID:12016162 sodium arsenite increases methylation ISO RGD:1344668 6480464 sodium arsenite results in increased methylation of NAT1 gene CTD PMID:25199682 Soman increases expression ISO RGD:70490 6480464 Soman results in increased expression of NAT1 mRNA CTD PMID:19281266 sulindac decreases expression ISO RGD:1344668 6480464 Sulindac results in decreased expression of NAT1 mRNA CTD PMID:11828994 sunitinib decreases expression ISO RGD:1344668 6480464 Sunitinib results in decreased expression of NAT1 mRNA CTD PMID:31533062 tamoxifen decreases response to substance ISO RGD:1344668 6480464 NAT1 protein results in decreased susceptibility to Tamoxifen CTD PMID:20628863 testosterone multiple interactions ISO RGD:1344668 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NAT1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1344668 6480464 Testosterone results in increased expression of NAT1 mRNA CTD PMID:21592394 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NAT1 mRNA CTD PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of NAT1 mRNA CTD PMID:23409001 toluene 2,4-diisocyanate affects response to substance ISO RGD:1344668 6480464 NAT1 gene polymorphism affects the susceptibility to Toluene 2, 4-Diisocyanate CTD PMID:18447907 toluene 2,4-diisocyanate increases response to substance ISO RGD:1344668 6480464 NAT1 protein polymorphism results in increased susceptibility to Toluene 2, 4-Diisocyanate CTD PMID:11927838 trichloroethene increases response to substance ISO RGD:1344668 6480464 NAT1 gene polymorphism results in increased susceptibility to Trichloroethylene CTD PMID:19834256 urethane increases expression ISO RGD:1344668 6480464 Urethane results in increased expression of NAT1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1344668 6480464 Valproic Acid results in decreased methylation of NAT1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1344668 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of NAT1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1344668 6480464 Valproic Acid results in increased expression of NAT1 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1344668 6480464 Valproic Acid affects the expression of NAT1 mRNA CTD PMID:25979313 wogonin decreases expression ISO RGD:1344668 6480464 wogonin results in decreased expression of NAT1 mRNA, wogonin results in decreased expression of NAT1 protein CTD PMID:15816529